The first generation of Reactive Oxygen® has been commercialised in the UK as a CE marked medical device called SurgihoneyRO™, this is in gel format and has proven extremely effective in real world settings, particularly against potent antibiotic resistant infections.

The Reactive Oxygen® technology platform is now being developed in a number of pathways, based on a refined and improved formula which is entirely synthetic and has proven to be more potent and stable than the first generation SurgihoneyRO™.

The first synthetic format is a gel known as RO-101®, which is a CE marked medical device intended to replicate the physical and antimicrobial characteristics of SurgihoneyRO™.